However, approximately 10%–20% of BC lacks expression of ER, PR, and HER‐2, categorizing it as triple‐negative breast cancer (TNBC), which is one of the most heterogeneous subtypes associated with an unfavorable prognosis.2 The gene discussed is ERBB2; the disease is breast cancer.